Literature DB >> 7983035

Production, purification, and characterization of recombinant maspin proteins.

S Sheng1, P A Pemberton, R Sager.   

Abstract

Maspin, a novel mammary serine protease inhibitor, was shown to have tumor suppressing activity (Zou, Z., Anisowicz, A., Hendrix, M. J. C., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., and Sager, R. (1994) Science 263, 526-529). In this paper, we report the production of recombinant glutathione S-transferase-maspin fusion protein, expressed in the bacterium Escherichia coli, and recombinant maspin, expressed in the insect Spodoptera frugiperda cells. The fusion protein was purified by glutathione affinity chromatography. Maspin expressed in insect cells was purified by a combination of Bio-Rad AG1-2X anion exchange chromatography and heparin affinity chromatography. The recombinant maspin from insect cells was cleaved at the putative reactive center, as confirmed by protein sequencing. Both recombinant proteins demonstrated strong inhibitory effects on the invasion by two breast tumor cell lines across reconstituted basement membranes and such inhibitory effect was abolished in the presence of the polyclonal antibody made against the reactive center region of maspin. The trypsin-cleaved recombinant maspin did not inhibit invasion, indicating that the inhibitory activity requires the intact putative reactive center. This paper provides evidence that recombinant maspin protein itself inhibits invasion, and supports the role of maspin as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983035

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.

Authors:  M Zhang; S Sheng; N Maass; R Sager
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

Review 2.  The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin.

Authors:  Margarida M Bernardo; Sijana H Dzinic; Maria J Matta; Ivory Dean; Lina Saker; Shijie Sheng
Journal:  J Cell Biochem       Date:  2017-03-21       Impact factor: 4.429

Review 3.  Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.

Authors:  Thomas J Wilson; Rakesh K Singh
Journal:  Biochim Biophys Acta       Date:  2007-11-26

4.  An Essential Role of Maspin in Embryogenesis and Tumor Suppression.

Authors:  Sijana H Dzinic; M Margarida Bernardo; Xiaohua Li; Rodrigo Fernandez-Valdivia; Ye-Shih Ho; Qing-Sheng Mi; Sudeshna Bandyopadhyay; Fulvio Lonardo; Semir Vranic; Daniel S M Oliveira; R Daniel Bonfil; Gregory Dyson; Kang Chen; Almasa Omerovic; Xiujie Sheng; Xiang Han; Dinghong Wu; Xinling Bi; Dzenana Cabaravdic; Una Jakupovic; Marian Wahba; Aaron Pang; Deanna Harajli; Wael A Sakr; Shijie Sheng
Journal:  Cancer Res       Date:  2016-12-06       Impact factor: 12.701

5.  Internalization by multiple endocytic pathways and lysosomal processing impact maspin-based therapeutics.

Authors:  Thomas M Bodenstine; Richard E B Seftor; Elisabeth A Seftor; Zhila Khalkhali-Ellis; Nicole A Samii; J Cesar Monarrez; Grace S Chandler; Philip A Pemberton; Mary J C Hendrix
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

6.  Maspin suppresses survival of lung cancer cells through modulation of Akt pathway.

Authors:  Eunsook Nam; Chaehwa Park
Journal:  Cancer Res Treat       Date:  2010-03-31       Impact factor: 4.679

7.  Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis.

Authors:  Anastasios Tahmatzopoulos; Shijie Sheng; Natasha Kyprianou
Journal:  Oncogene       Date:  2005-08-11       Impact factor: 9.867

8.  Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.

Authors:  S Sheng; J Carey; E A Seftor; L Dias; M J Hendrix; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

9.  Expression of maspin is associated with the intestinal type of gastric adenocarcinoma.

Authors:  Seong Man Kim; Seong Jin Cho; Woo Young Jang; Duck Hwan Kim; Hyung Sik Shin; Myoung Kuk Jang; Hak Yang Kim; Eun Sook Nam
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

10.  Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.

Authors:  Mark A Horswill; Malathi Narayan; Debra J Warejcka; Lisa A Cirillo; Sally S Twining
Journal:  Exp Eye Res       Date:  2008-01-12       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.